BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10611569)

  • 1. [131I-treatment of the autonomous toxic nodule. Assessment of a fixed dose protocol].
    Abós MD; Banzo J; Razola P; García F; Prats E
    Rev Esp Med Nucl; 1999 Dec; 18(6):431-5. PubMed ID: 10611569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment with (131)I of toxic multinodular goiter. Assessment of a fixed dose protocol].
    Abós MD; Banzo J; Razola P; García F; Prats E
    Rev Esp Med Nucl; 2000 Jun; 19(3):182-6. PubMed ID: 11062080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up in toxic solitary autonomous thyroid nodules treated with radioactive iodine.
    Huysmans DA; Corstens FH; Kloppenborg PW
    J Nucl Med; 1991 Jan; 32(1):27-30. PubMed ID: 1988632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 131I therapy of toxic and non-toxic goiters.
    Beckers C
    Q J Nucl Med; 1999 Dec; 43(4):291-6. PubMed ID: 10731779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
    Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
    Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome.
    Walter MA; Christ-Crain M; Eckard B; Schindler C; Nitzsche EU; Müller-Brand J; Müller B
    Eur J Clin Invest; 2004 May; 34(5):365-70. PubMed ID: 15147334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follow-up of solitary autonomous thyroid nodules treated with 131I.
    Goldstein R; Hart IR
    N Engl J Med; 1983 Dec; 309(24):1473-6. PubMed ID: 6646172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of Graves-Basedow's disease with 131I. Assessment of a "modulated fixed activity" protocol].
    Abós D; Ruiz P; Prats E; Razola P; García F; Tardín L; Banzo J
    Rev Esp Med Nucl; 2007; 26(1):3-10. PubMed ID: 17286943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness of radioactive iodine in the treatment of toxic adenoma: results of our experience with a group of 17 patients and review of the literature].
    Melián E; Cuellar L; Estopiñán V; Riobó P; Lara JI; Sánchez-Franco F
    Med Clin (Barc); 1988 Mar; 90(9):366-8. PubMed ID: 3292865
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Iodine-131 therapy of autonomous adenoma of the thyroid. 7-year results].
    Heinze HG; Bohn U
    Dtsch Med Wochenschr; 1987 Jul; 112(27):1073-9. PubMed ID: 3595467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonimmunogenic hyperthyroidism: cumulative hypothyroidism incidence after radioiodine and surgical treatment.
    Kinser JA; Roesler H; Furrer T; Grütter D; Zimmermann H
    J Nucl Med; 1989 Dec; 30(12):1960-5. PubMed ID: 2585096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metabolic radiotherapy of hyperthyroidism].
    Salvatore M; Brunetti A
    Ann Ital Chir; 1989; 60(5):367-71. PubMed ID: 2699388
    [No Abstract]   [Full Text] [Related]  

  • 14. Early change of thyroid hormone concentration after 131I treatment in patients with solitary toxic adenoma.
    Pirnat E; Fidler V; Zaletel K; Gaberscek S; Hojker S
    Nuklearmedizin; 2002; 41(4):178-83. PubMed ID: 12224401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radio-iodine therapy of toxic adenoma of the thyroid (author's transl)].
    Heinze HG; Pfeifer KJ; Lichtenstein Z
    Dtsch Med Wochenschr; 1975 Oct; 100(43):2203-8. PubMed ID: 1175469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of radioiodine treatment of patients with immunogenic and non-immunogenic hyperthyroidism using different focal doses].
    Moser E; Pickardt CR; Mann K; Engelhardt D; Kirsch CM; Knesewitsch P; Tatsch K; Kreisig T; Kurz C; Saller B
    Nuklearmedizin; 1988 Jun; 27(3):98-104. PubMed ID: 3405782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioactive iodine in the treatment of Graves' disease.
    Al-Kaabi JM; Hussein SS; Bukheit CS; Woodhouse NJ; Elshafie OT; Bererhi H
    Saudi Med J; 2002 Sep; 23(9):1049-53. PubMed ID: 12370710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of treatment of Graves-Basedow disease with 131I at low calculated doses].
    Gómez Arnaiz N; Gómez Saez JM; Orti Llavería A; Gavaldá Mestre L; Mairal Pairó L; Soler Ramón J
    Rev Clin Esp; 1998 Feb; 198(2):57-60. PubMed ID: 9558917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of radioiodine (131/125I) therapy of hyperthyroidism.
    Glanzmann C; Horst W; Magdeburg W
    Radiol Clin (Basel); 1975; 44(5):484-90. PubMed ID: 1208842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of solitary toxic thyroid nodule with 131I: results in 43 patients].
    Marín JF; Maraña G; Salto L; Astigarraga B; Estrada FJ; Lucas T; Barceló B
    Med Clin (Barc); 1991 May; 96(19):730-2. PubMed ID: 1875750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.